Kura Oncology (KURA) Reports In-Line Q4 EPS
Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.55), in-line with the analyst estimate of ($0.55).
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.55), in-line with the analyst estimate of ($0.55).
For earnings history and earnings-related data on Kura Oncology (KURA) click here.